Trial Profile
A randomized, double-blind, vehicle-controlled study of VB-1953 in patients with moderate to severe acne
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs VB 1953 (Primary)
- Indications Acne
- Focus Proof of concept; Therapeutic Use
- 26 Apr 2017 New trial record
- 24 Apr 2017 Results from this trial are expected later in 2017, according to a Vyome Biosciences media release.